Lotte M E Berghauser Pont's research works | Erasmus MC, Rotterdam (Erasmus MC) and other places
RePub, Erasmus University Repository: ABT-888 enhances cytotoxic effects of temozolomide independent of MGMT status in serum free cultured glioma cells
Self-learning: The dawn of a new biomedical R&D paradigm | McKinsey
Lotte M E Berghauser Pont's research works | Erasmus MC, Rotterdam (Erasmus MC) and other places
PDF) Letter to the Editor: Deep venous thrombosis and pulmonary embolism | Ruben Dammers - Academia.edu
Lotte M E Berghauser Pont's research works | Erasmus MC, Rotterdam (Erasmus MC) and other places
Tobias Silberzahn on LinkedIn: #digitalhealth #healthtech #futureofhealth
Developing blockbuster drugs: both nature and nurture
Self-learning: The dawn of a new biomedical R&D paradigm | McKinsey
Lotte M E Berghauser Pont's research works | Erasmus MC, Rotterdam (Erasmus MC) and other places
Innovation sourcing in biopharma: Four practices to maximize success | McKinsey
The HDAC Inhibitors Scriptaid and LBH589 Combined with the Oncolytic Virus Delta24-RGD Exert Enhanced Anti-Tumor Efficacy in Patient-Derived Glioblastoma Cells | PLOS ONE
Lotte M E Berghauser Pont's research works | Erasmus MC, Rotterdam (Erasmus MC) and other places
Lotte M E Berghauser Pont's research works | Erasmus MC, Rotterdam (Erasmus MC) and other places
Lotte M E Berghauser Pont's research works | Erasmus MC, Rotterdam (Erasmus MC) and other places
Developing blockbuster drugs: both nature and nurture
Innovation sourcing in biopharma: Four practices to maximize success | McKinsey
Lotte M E Berghauser Pont's research works | Erasmus MC, Rotterdam (Erasmus MC) and other places
Impact of COVID-19 on pharmaceutical external innovation sourcing
Lotte M E Berghauser Pont's research works | Erasmus MC, Rotterdam (Erasmus MC) and other places
Lotte M E Berghauser Pont's research works | Erasmus MC, Rotterdam (Erasmus MC) and other places
Innovation sourcing in biopharma: Four practices to maximize success | McKinsey
Innovation sourcing in biopharma: Four practices to maximize success | McKinsey
Lotte | McKinsey & Company
Therapeutic concentrations of antiâ•'epileptic drugs do not inhibit the activity of the oncolytic adenovirus Delta24â•
